KIR3DL1 and HLA-B subtype combinations predict the efficacy of 3F8 monoclonal antibody therapy for neuroblastoma Meeting Abstract


Authors: Forlenza, C. J.; Boudreau, J. E.; Zheng, J.; Heller, G.; Cheung, N. K. V.; Hsu, K. C.
Abstract Title: KIR3DL1 and HLA-B subtype combinations predict the efficacy of 3F8 monoclonal antibody therapy for neuroblastoma
Meeting Title: 106th Annual Meeting of the American Association for Cancer Research (AACR)
Journal Title: Cancer Research
Volume: 75
Issue: 15 Suppl.
Meeting Dates: 2015 Apr 18-22
Meeting Location: Philadelphia, PA
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2015-08-01
Language: English
ACCESSION: WOS:000371578505060
DOI: 10.1158/1538-7445.am2015-2459
PROVIDER: wos
Notes: Meeting Abstract: 2459 -- Proceedings of the 106th Annual Meeting of the American Association for Cancer Research -- Source: Wos
Altmetric Score
MSK Authors
  1. Junting Zheng
    131 Zheng
  2. Glenn Heller
    303 Heller
  3. Nai-Kong Cheung
    446 Cheung
  4. Katharine C Hsu
    136 Hsu